BBVA USA Bancshares’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $6.36M | Buy |
74,414
+6,320
| +9% | +$567K | 0.3% | 86 |
|
|
2020
Q4 | $6.43M | Sell |
68,094
-6,534
| -9% | -$571K | 0.33% | 78 |
|
|
2020
Q3 | $6.49M | Buy |
74,628
+715
| +1% | +$61.9K | 0.37% | 66 |
|
|
2020
Q2 | $6.46M | Buy |
73,913
+7,704
| +12% | +$665K | 0.39% | 66 |
|
|
2020
Q1 | $5.46M | Buy |
66,209
+28,498
| +76% | +$2.54M | 0.39% | 65 |
|
|
2019
Q4 | $3.57M | Buy |
37,711
+397
| +1% | +$35.6K | 0.2% | 115 |
|
|
2019
Q3 | $3.24M | Sell |
37,314
-1,350
| -3% | -$121K | 0.21% | 119 |
|
|
2019
Q2 | $3.53M | Sell |
38,664
-1,960
| -5% | -$166K | 0.21% | 115 |
|
|
2019
Q1 | $3.5M | Buy |
40,624
+189
| +0.5% | +$15.2K | 0.22% | 109 |
|
|
2018
Q4 | $3.11M | Sell |
40,435
-1,292
| -3% | -$101K | 0.22% | 104 |
|
|
2018
Q3 | $3.22M | Sell |
41,727
-39
| -0.1% | -$2.88K | 0.19% | 122 |
|
|
2018
Q2 | $2.83M | Sell |
41,766
-2,441
| -6% | -$168K | 0.18% | 126 |
|
|
2018
Q1 | $3.2M | Sell |
44,207
-2,155
| -5% | -$164K | 0.21% | 111 |
|
|
2017
Q4 | $3.49M | Sell |
46,362
-2,146
| -4% | -$162K | 0.22% | 105 |
|
|
2017
Q3 | $3.73M | Buy |
48,508
+549
| +1% | +$41.5K | 0.24% | 98 |
|
|
2017
Q2 | $3.59M | Sell |
47,959
-1,139
| -2% | -$80.7K | 0.24% | 100 |
|
|
2017
Q1 | $3.27M | Sell |
49,098
-657
| -1% | -$43.8K | 0.22% | 109 |
|
|
2016
Q4 | $3.25M | Sell |
49,755
-25,700
| -34% | -$1.67M | 0.23% | 107 |
|
|
2016
Q3 | $5.34M | Buy |
75,455
+5,204
| +7% | +$379K | 0.39% | 66 |
|
|
2016
Q2 | $5.19M | Buy |
70,251
+1,881
| +3% | +$130K | 0.39% | 67 |
|
|
2016
Q1 | $4.44M | Buy |
68,370
+10,778
| +19% | +$733K | 0.33% | 74 |
|
|
2015
Q4 | $4.44M | Sell |
57,592
-7,961
| -12% | -$632K | 0.33% | 79 |
|
|
2015
Q3 | $5.4M | Buy |
65,553
+5,093
| +8% | +$453K | 0.42% | 66 |
|
|
2015
Q2 | $5.33M | Buy |
60,460
+7,322
| +14% | +$672K | 0.3% | 93 |
|
|
2015
Q1 | $4.7M | Buy |
53,138
+5,795
| +12% | +$514K | 0.21% | 138 |
|
|
2014
Q4 | $3.93M | Buy |
47,343
+8,361
| +21% | +$693K | 0.18% | 150 |
|
|
2014
Q3 | $3.29M | Buy |
38,982
+27,071
| +227% | +$2.19M | 0.15% | 161 |
|
|
2014
Q2 | $966K | Buy |
11,911
+894
| +8% | +$70.3K | 0.04% | 280 |
|
|
2014
Q1 | $839K | Buy |
11,017
+386
| +4% | +$28.1K | 0.04% | 292 |
|
|
2013
Q4 | $766K | Buy |
10,631
+3,352
| +46% | +$233K | 0.03% | 297 |
|
|
2013
Q3 | $500K | Buy |
7,279
+1,389
| +24% | +$91.9K | 0.02% | 327 |
|
|
2013
Q2 | $374K | Buy |
+5,890
| New | +$383K | 0.02% | 349 |
|
Other funds holding NVS
BBVA USA Bancshares's NVS Position: Q1 2021 in Review
BBVA USA Bancshares increased its Novartis (NVS) stake by 9.3% in Q1 2021, buying an estimated $567K and bringing the position to 74,414 shares worth $6.36M. The position accounts for 0.3% of the portfolio, ranked #86.
BBVA USA Bancshares first reported a position in NVS in Q2 2013 and has held it in 32 quarters since. The position peaked at $6.49M in Q3 2020. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2021.
- BBVA USA Bancshares held 74,414 shares of Novartis worth $6.36M as of Q1 2021.
- BBVA USA Bancshares bought 6,320 Novartis shares in Q1 2021, an estimated $567K.
- Novartis made up 0.3% of BBVA USA Bancshares's portfolio in Q1 2021, its #86 holding.
- BBVA USA Bancshares first reported a position in Novartis in Q2 2013 and has held it in 32 quarters since.
- BBVA USA Bancshares's Novartis position peaked at $6.49M in Q3 2020.
- 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.